{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T12:31:39Z","timestamp":1786365099387,"version":"build-2736575974"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82102877"],"award-info":[{"award-number":["82102877"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017369","name":"Scientific and Technological Planning Project of Guangzhou City","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017369","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2021A1515010083"],"award-info":[{"award-number":["2021A1515010083"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2022A1515111118"],"award-info":[{"award-number":["2022A1515111118"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.intimp.2024.112797","type":"journal-article","created":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T22:48:45Z","timestamp":1722293325000},"page":"112797","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Alterations in intratumoral and peripheral immune status in recurrent gliomas and their prognostic implications for patients underwent reoperation"],"prefix":"10.1016","volume":"140","author":[{"given":"Ailian","family":"Ou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanming","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pingping","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongqiang","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Ke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonggao","family":"Mou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Sai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4317-1606","authenticated-orcid":false,"given":"Depei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.intimp.2024.112797_b0005","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1093\/neuonc\/noz233","article-title":"Toward a standard pathological and molecular characterization of recurrent glioma in adults: a Response Assessment in Neuro-Oncology effort","volume":"22","author":"Haider","year":"2020","journal-title":"Neuro Oncol."},{"issue":"5","key":"10.1016\/j.intimp.2024.112797_b0010","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1227\/NEU.0000000000000486","article-title":"Reoperation for recurrent high-grade glioma: a current perspective of the literature","volume":"75","author":"Hervey-Jumper","year":"2014","journal-title":"Neurosurgery"},{"issue":"7","key":"10.1016\/j.intimp.2024.112797_b0015","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1038\/ng.3590","article-title":"Clonal evolution of glioblastoma under therapy","volume":"48","author":"Wang","year":"2016","journal-title":"Nat. Genet."},{"issue":"12","key":"10.1016\/j.intimp.2024.112797_b0020","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1038\/s43018-022-00475-x","article-title":"A single-cell atlas of glioblastoma evolution under therapy reveals cell-intrinsic and cell-extrinsic therapeutic targets","volume":"3","author":"Wang","year":"2022","journal-title":"Nat Cancer"},{"issue":"1","key":"10.1016\/j.intimp.2024.112797_b0025","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ccell.2017.06.003","article-title":"Tumor Evolution of Glioma-Intrinsic Gene Expression Subtypes Associates with Immunological Changes in the Microenvironment","volume":"32","author":"Wang","year":"2017","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.intimp.2024.112797_b0030","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.celrep.2016.12.019","article-title":"Pan-cancer Immunogenomic Analyses Reveal Genotype-Immunophenotype Relationships and Predictors of Response to Checkpoint Blockade","volume":"18","author":"Charoentong","year":"2017","journal-title":"Cell Rep."},{"issue":"17","key":"10.1016\/j.intimp.2024.112797_b0035","doi-asserted-by":"crossref","first-page":"4187","DOI":"10.1158\/1078-0432.CCR-17-2617","article-title":"Immunophenotyping of Newly Diagnosed and Recurrent Glioblastoma Defines Distinct Immune Exhaustion Profiles in Peripheral and Tumor-infiltrating Lymphocytes","volume":"24","author":"Mohme","year":"2018","journal-title":"Clin. Cancer Res."},{"issue":"11","key":"10.1016\/j.intimp.2024.112797_b0040","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/j.prp.2017.09.017","article-title":"Identification of P4HA1 as a prognostic biomarker for high-grade gliomas","volume":"213","author":"Hu","year":"2017","journal-title":"Pathol. Res. Pract."},{"issue":"1","key":"10.1016\/j.intimp.2024.112797_b0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.gpb.2020.10.005","article-title":"Chinese Glioma Genome Atlas (CGGA): A Comprehensive Resource with Functional Genomic Data from Chinese Glioma Patients","volume":"19","author":"Zhao","year":"2021","journal-title":"Genomics Proteomics Bioinformatics"},{"issue":"2","key":"10.1016\/j.intimp.2024.112797_b0050","doi-asserted-by":"crossref","first-page":"520","DOI":"10.3390\/cancers12020520","article-title":"Intratumoral Heterogeneity and Longitudinal Changes in Gene Expression Predict Differential Drug Sensitivity in Newly Diagnosed and Recurrent Glioblastoma","volume":"12","author":"Kim","year":"2020","journal-title":"Cancers (basel)"},{"issue":"2","key":"10.1016\/j.intimp.2024.112797_b0055","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/s41596-018-0103-9","article-title":"Pathway enrichment analysis and visualization of omics data using g:Profiler, GSEA","volume":"14","author":"Reimand","year":"2019","journal-title":"Cytoscape and EnrichmentMap. Nat Protoc"},{"issue":"12","key":"10.1016\/j.intimp.2024.112797_b0060","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1093\/bioinformatics\/btr260","article-title":"Molecular signatures database (MSigDB) 3.0","volume":"27","author":"Liberzon","year":"2011","journal-title":"Bioinformatics"},{"key":"10.1016\/j.intimp.2024.112797_b0065","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1038\/ncomms3612","article-title":"Inferring tumour purity and stromal and immune cell admixture from expression data","volume":"4","author":"Yoshihara","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2024.112797_b0070","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2105-14-7","article-title":"GSVA: gene set variation analysis for microarray and RNA-seq data","volume":"14","author":"H\u00e4nzelmann","year":"2013","journal-title":"BMC Bioinf."},{"issue":"7","key":"10.1016\/j.intimp.2024.112797_b0075","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/s41587-019-0114-2","article-title":"Determining cell type abundance and expression from bulk tissues with digital cytometry","volume":"37","author":"Newman","year":"2019","journal-title":"Nat. Biotechnol."},{"issue":"1","key":"10.1016\/j.intimp.2024.112797_b0080","doi-asserted-by":"crossref","first-page":"6938","DOI":"10.1038\/s41467-021-26940-2","article-title":"Neoadjuvant PD-1 blockade induces T cell and cDC1 activation but fails to overcome the immunosuppressive tumor associated macrophages in recurrent glioblastoma","volume":"12","author":"Lee","year":"2021","journal-title":"Nat. Commun."},{"issue":"29","key":"10.1016\/j.intimp.2024.112797_b0085","doi-asserted-by":"crossref","first-page":"861","DOI":"10.21105\/joss.00861","article-title":"UMAP: Uniform Manifold Approximation and Projection","volume":"3","author":"McInnes","year":"2018","journal-title":"Journal of Open Source Software"},{"issue":"D1","key":"10.1016\/j.intimp.2024.112797_b0090","doi-asserted-by":"crossref","first-page":"D457-462","DOI":"10.1093\/nar\/gkv1070","article-title":"KEGG as a reference resource for gene and protein annotation","volume":"44","author":"Kanehisa","year":"2016","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.intimp.2024.112797_b0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110609","article-title":"Metabolism drives macrophage heterogeneity in the tumor microenvironment","volume":"39","author":"Li","year":"2022","journal-title":"Cell Rep."},{"issue":"2","key":"10.1016\/j.intimp.2024.112797_b0100","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20210564","article-title":"Lipid-loaded tumor-associated macrophages sustain tumor growth and invasiveness in prostate cancer","volume":"219","author":"Masetti","year":"2022","journal-title":"J. Exp. Med."},{"issue":"W1","key":"10.1016\/j.intimp.2024.112797_b0105","doi-asserted-by":"crossref","first-page":"W556","DOI":"10.1093\/nar\/gkz430","article-title":"GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis","volume":"47","author":"Tang","year":"2019","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.intimp.2024.112797_b0110","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1186\/s13059-017-1362-4","article-title":"Single-cell profiling of human gliomas reveals macrophage ontogeny as a basis for regional differences in macrophage activation in the tumor microenvironment","volume":"18","author":"M\u00fcller","year":"2017","journal-title":"Genome Biol."},{"issue":"1","key":"10.1016\/j.intimp.2024.112797_b0115","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/s41591-019-0694-x","article-title":"Immune profiling of human tumors identifies CD73 as a combinatorial target in glioblastoma","volume":"26","author":"Goswami","year":"2020","journal-title":"Nat. Med."},{"issue":"20","key":"10.1016\/j.intimp.2024.112797_b0120","doi-asserted-by":"crossref","first-page":"5287","DOI":"10.1158\/1078-0432.CCR-20-1135","article-title":"PD-1 Inhibitors: Do they have a Future in the Treatment of Glioblastoma?","volume":"26","author":"Khasraw","year":"2020","journal-title":"Clin. Cancer Res."},{"issue":"7","key":"10.1016\/j.intimp.2024.112797_b0125","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nrclinonc.2016.217","article-title":"Tumour-associated macrophages as treatment targets in oncology","volume":"14","author":"Mantovani","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.intimp.2024.112797_b0130","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/s13046-019-1151-x","article-title":"Lipolytic inhibitor G0S2 modulates glioma stem-like cell radiation response","volume":"38","author":"Wang","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"8","key":"10.1016\/j.intimp.2024.112797_b0135","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/s41419-022-05175-z","article-title":"CircKIF4A promotes glioma growth and temozolomide resistance by accelerating glycolysis","volume":"13","author":"Luo","year":"2022","journal-title":"Cell Death Dis."},{"issue":"4","key":"10.1016\/j.intimp.2024.112797_b0140","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/s41593-020-00789-y","article-title":"Single-cell profiling of myeloid cells in glioblastoma across species and disease stage reveals macrophage competition and specialization","volume":"24","author":"Pombo Antunes","year":"2021","journal-title":"Nat. Neurosci."},{"issue":"1","key":"10.1016\/j.intimp.2024.112797_b0145","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s11060-014-1366-9","article-title":"Factors impacting survival following second surgery in patients with glioblastoma in the temozolomide treatment era, incorporating neutrophil\/lymphocyte ratio and time to first progression","volume":"117","author":"McNamara","year":"2014","journal-title":"J. Neurooncol"},{"issue":"1","key":"10.1016\/j.intimp.2024.112797_b0150","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1038\/s41598-019-40024-8","article-title":"Elevated red cell distribution width to platelet count ratio predicts poor prognosis in patients with breast cancer","volume":"9","author":"Takeuchi","year":"2019","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.intimp.2024.112797_b0155","doi-asserted-by":"crossref","first-page":"e1601478","DOI":"10.1080\/2162402X.2019.1601478","article-title":"Molecular and clinical characterization of CD163 expression via large-scale analysis in glioma","volume":"8","author":"Liu","year":"2019","journal-title":"OncoImmunology"},{"issue":"1","key":"10.1016\/j.intimp.2024.112797_b0160","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s11060-022-04053-0","article-title":"Comparison of tumor immune environment between newly diagnosed and recurrent glioblastoma including matched patients","volume":"159","author":"Wang","year":"2022","journal-title":"J. Neurooncol"},{"issue":"24","key":"10.1016\/j.intimp.2024.112797_b0165","doi-asserted-by":"crossref","first-page":"6178","DOI":"10.3390\/cancers13246178","article-title":"Sustained Accumulation of Blood-Derived Macrophages in the Immune Microenvironment of Patients with Recurrent Glioblastoma after Therapy","volume":"13","author":"Magri","year":"2021","journal-title":"Cancers (basel)"},{"key":"10.1016\/j.intimp.2024.112797_b0170","doi-asserted-by":"crossref","first-page":"835","DOI":"10.3389\/fimmu.2020.00835","article-title":"Single-Cell Atlas Reveals Complexity of the Immunosuppressive Microenvironment of Initial and Recurrent Glioblastoma","volume":"11","author":"Fu","year":"2020","journal-title":"Front. Immunol."},{"issue":"7637","key":"10.1016\/j.intimp.2024.112797_b0175","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nature21349","article-title":"Elements of cancer immunity and the cancer\u2013immune set point","volume":"541","author":"Chen","year":"2017","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.intimp.2024.112797_b0180","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s13045-022-01298-0","article-title":"Translational landscape of glioblastoma immunotherapy for physicians: guiding clinical practice with basic scientific evidence","volume":"15","author":"Kreatsoulas","year":"2022","journal-title":"J. Hematol. Oncol."},{"issue":"4","key":"10.1016\/j.intimp.2024.112797_b0185","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.immuni.2019.03.024","article-title":"Transforming Growth Factor-\u03b2 Signaling in Immunity and Cancer","volume":"50","author":"Batlle","year":"2019","journal-title":"Immunity"},{"issue":"18","key":"10.1016\/j.intimp.2024.112797_b0190","doi-asserted-by":"crossref","first-page":"3321","DOI":"10.1158\/0008-5472.CAN-22-0507","article-title":"\u03b22-Microglobulin Maintains Glioblastoma Stem Cells and Induces M2-like Polarization of Tumor-Associated Macrophages","volume":"82","author":"Li","year":"2022","journal-title":"Cancer Res."},{"issue":"8","key":"10.1016\/j.intimp.2024.112797_b0195","doi-asserted-by":"crossref","first-page":"2930","DOI":"10.1172\/JCI91190","article-title":"IFN-\u03b3-related mRNA profile predicts clinical response to PD-1 blockade","volume":"127","author":"Ayers","year":"2017","journal-title":"J. Clin. Invest."},{"issue":"200","key":"10.1016\/j.intimp.2024.112797_b0200","doi-asserted-by":"crossref","first-page":"200ra116","DOI":"10.1126\/scitranslmed.3006504","article-title":"Up-regulation of PD-L1, IDO, and T(regs) in the melanoma tumor microenvironment is driven by CD8(+) T cells","volume":"5","author":"Spranger","year":"2013","journal-title":"Sci. Transl. Med."},{"issue":"1","key":"10.1016\/j.intimp.2024.112797_b0205","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1186\/s12974-018-1330-2","article-title":"The IFN-\u03b3\/PD-L1 axis between T cells and tumor microenvironment: hints for glioma anti-PD-1\/PD-L1 therapy","volume":"15","author":"Qian","year":"2018","journal-title":"J. Neuroinflammation"},{"issue":"1","key":"10.1016\/j.intimp.2024.112797_b0210","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12943-021-01486-5","article-title":"Immunometabolic rewiring in tumorigenesis and anti-tumor immunotherapy","volume":"21","author":"Lian","year":"2022","journal-title":"Mol. Cancer"},{"issue":"7","key":"10.1016\/j.intimp.2024.112797_b0215","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1158\/0008-5472.CAN-19-2994","article-title":"Enhanced Lipid Accumulation and Metabolism Are Required for the Differentiation and Activation of Tumor-Associated Macrophages","volume":"80","author":"Su","year":"2020","journal-title":"Cancer Res."},{"issue":"10","key":"10.1016\/j.intimp.2024.112797_b0220","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.ccell.2022.08.012","article-title":"Increased glucose metabolism in TAMs fuels O-GlcNAcylation of lysosomal Cathepsin B to promote cancer metastasis and chemoresistance","volume":"40","author":"Shi","year":"2022","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.intimp.2024.112797_b0225","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/s41392-021-00505-7","article-title":"Administration of B7\u2013H3 targeted chimeric antigen receptor-T cells induce regression of glioblastoma","volume":"6","author":"Tang","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.intimp.2024.112797_b0230","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1158\/1078-0432.CCR-15-1535","article-title":"Combination Therapy with Anti-PD-1, Anti-TIM-3, and Focal Radiation Results in Regression of Murine Gliomas","volume":"23","author":"Kim","year":"2017","journal-title":"Clin. Cancer Res."},{"issue":"4","key":"10.1016\/j.intimp.2024.112797_b0235","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-004424","article-title":"Dual checkpoint targeting of B7\u2013H3 and PD-1 with enoblituzumab and pembrolizumab in advanced solid tumors: interim results from a multicenter phase I\/II trial","volume":"10","author":"Aggarwal","year":"2022","journal-title":"J. Immunother. Cancer"},{"issue":"13","key":"10.1016\/j.intimp.2024.112797_b0240","doi-asserted-by":"crossref","first-page":"3620","DOI":"10.1158\/1078-0432.CCR-20-4746","article-title":"Phase I\/Ib Clinical Trial of Sabatolimab, an Anti-TIM-3 Antibody, Alone and in Combination with Spartalizumab, an Anti-PD-1 Antibody","volume":"27","author":"Curigliano","year":"2021","journal-title":"Advanced Solid Tumors. Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.intimp.2024.112797_b0245","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1158\/2159-8290.CD-22-0750","article-title":"Intraventricular B7\u2013H3 CAR T Cells for Diffuse Intrinsic Pontine Glioma: Preliminary First-in-Human Bioactivity and Safety","volume":"13","author":"Vitanza","year":"2023","journal-title":"Cancer Discov."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924013183?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924013183?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T11:58:14Z","timestamp":1786363094000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576924013183"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":49,"alternative-id":["S1567576924013183"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2024.112797","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Alterations in intratumoral and peripheral immune status in recurrent gliomas and their prognostic implications for patients underwent reoperation","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2024.112797","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"112797"}}